BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behnam Sani K, Sawitzki B. Immune monitoring as prerequisite for transplantation tolerance trials. Clin Exp Immunol 2017;189:158-70. [PMID: 28518214 DOI: 10.1111/cei.12988] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Klaeske K, Lehmann S, Büttner P, Palitzsch R, Fischer J, Jawad K, Garbade J, Borger MA, Barten MJ, Dieterlen M. Identification of the immunological profile in rejection-free heart transplantation. Transplant Immunology 2020;59:101259. [DOI: 10.1016/j.trim.2019.101259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Bontha SV, Fernandez-Piñeros A, Maluf DG, Mas VR. Messengers of tolerance. Hum Immunol 2018;79:362-72. [PMID: 29402484 DOI: 10.1016/j.humimm.2018.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Gandolfini I, Crespo E, Baweja M, Jarque M, Donadei C, Luque S, Montero N, Allesina A, Perin L, Maggiore U, Cravedi P, Bestard O. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation. PLoS One 2018;13:e0200696. [PMID: 30059561 DOI: 10.1371/journal.pone.0200696] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chan-On C, Liberto JM, Sarwal MM. Mechanisms and biomarkers of immune quiescence in kidney transplantation. Hum Immunol. 2018;79:356-361. [PMID: 29408630 DOI: 10.1016/j.humimm.2018.01.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Lee KW, Park JB, Park H, Kwon Y, Lee JS, Kim KS, Chung YJ, Rhu JS, Choi S, Kwon GY, Kim HJ, Kang ES, Jung CW, Shin EC, Kawai T, Kim SJ, Joh JW. Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization. Transplantation 2020;104:1472-82. [PMID: 31634324 DOI: 10.1097/TP.0000000000003006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Lynch K, Treacy O, Gerlach JQ, Annuk H, Lohan P, Cabral J, Joshi L, Ryan AE, Ritter T. Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment. Front Immunol 2017;8:1427. [PMID: 29163502 DOI: 10.3389/fimmu.2017.01427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lei H, Reinke P, Volk HD, Lv Y, Wu R. Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects. Front Immunol 2019;10:2667. [PMID: 31803188 DOI: 10.3389/fimmu.2019.02667] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
8 Crowley LE, Mekki M, Chand S. Biomarkers and Pharmacogenomics in Kidney Transplantation. Mol Diagn Ther 2018;22:537-50. [PMID: 29971647 DOI: 10.1007/s40291-018-0349-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wekerle T. Immune tolerance in transplantation. Clin Exp Immunol 2017;189:133-4. [PMID: 28703287 DOI: 10.1111/cei.12994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Kholodenko IV, Kholodenko RV, Lupatov AY, Yarygin KN. Cell Therapy as a Tool for Induction of Immunological Tolerance after Liver Transplantation. Bull Exp Biol Med 2018;165:554-63. [PMID: 30121913 DOI: 10.1007/s10517-018-4213-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Mirzakhani M, Shahbazi M, Oliaei F, Mohammadnia-Afrouzi M. Immunological biomarkers of tolerance in human kidney transplantation: An updated literature review. J Cell Physiol 2019;234:5762-74. [PMID: 30362556 DOI: 10.1002/jcp.27480] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 van Dongen JJM, O'Gorman MRG, Orfao A. EuroFlow and its activities: Introduction to the special EuroFlow issue of The Journal of Immunological Methods. J Immunol Methods 2019;475:112704. [PMID: 31758969 DOI: 10.1016/j.jim.2019.112704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Bhat DK, Olkhanud PB, Gangaplara A, Seifuddin F, Pirooznia M, Biancotto A, Fantoni G, Pittman C, Francis B, Dagur PK, Saxena A, McCoy JP, Pfeiffer RM, Fitzhugh CD. Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease. Front Immunol 2021;12:757279. [PMID: 34917079 DOI: 10.3389/fimmu.2021.757279] [Reference Citation Analysis]